NYSE - Delayed Quote • USD
Laboratory Corporation of America Holdings (LH)
At close: April 25 at 4:00 PM EDT
Pre-Market: 4:09 AM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 15 | 15 | 18 | 18 |
Avg. Estimate | 3.48 | 3.84 | 14.82 | 16.04 |
Low Estimate | 3.3 | 3.75 | 14.45 | 15.38 |
High Estimate | 3.59 | 3.97 | 15 | 16.82 |
Year Ago EPS | 3.46 | 3.42 | 13.56 | 14.82 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 13 | 13 | 17 | 17 |
Avg. Estimate | 3.12B | 3.2B | 12.76B | 13.31B |
Low Estimate | 3.02B | 3.18B | 12.63B | 12.9B |
High Estimate | 3.16B | 3.25B | 12.83B | 13.55B |
Year Ago Sales | 3.78B | 3.03B | 12.16B | 12.76B |
Sales Growth (year/est) | -17.50% | 5.40% | 4.90% | 4.30% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 3.96 | 3.53 | 3.33 | 3.26 |
EPS Actual | 3.46 | 3.42 | 3.38 | 3.3 |
Difference | -0.5 | -0.11 | 0.05 | 0.04 |
Surprise % | -12.60% | -3.10% | 1.50% | 1.20% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 3.48 | 3.84 | 14.82 | 16.04 |
7 Days Ago | 3.48 | 3.84 | 14.82 | 16.04 |
30 Days Ago | 3.51 | 3.81 | 14.82 | 16.06 |
60 Days Ago | 3.51 | 3.78 | 14.8 | 16.07 |
90 Days Ago | 3.62 | 3.68 | 14.61 | 15.98 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | 2 | -- | -- |
Up Last 30 Days | -- | 3 | 2 | 4 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 2 | -- | 1 | 1 |
Growth Estimates
CURRENCY IN USD | LH | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 0.60% | -- | -- | 2.60% |
Next Qtr. | 12.30% | -- | -- | 13.40% |
Current Year | 9.30% | -- | -- | 5.20% |
Next Year | 8.20% | -- | -- | 13.30% |
Next 5 Years (per annum) | 8.36% | -- | -- | 11.11% |
Past 5 Years (per annum) | 8.18% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Upgrade | Argus Research: Hold to Buy | 3/25/2024 |
Initiated | Leerink Partners: Outperform | 2/26/2024 |
Initiated | Evercore ISI Group: In-Line | 2/9/2024 |
Initiated | Barclays: Equal-Weight | 1/3/2024 |
Maintains | JP Morgan: Overweight to Overweight | 11/17/2023 |
Maintains | Mizuho: Buy to Buy | 10/31/2023 |
Related Tickers
DGX Quest Diagnostics Incorporated
135.42
-1.55%
NVTAQ Invitae Corporation
0.0090
+800.00%
TMO Thermo Fisher Scientific Inc.
571.73
-0.98%
CRL Charles River Laboratories International, Inc.
227.81
-4.85%
ICLR ICON Public Limited Company
300.08
-3.02%
DHR Danaher Corporation
245.80
-1.84%
MEDP Medpace Holdings, Inc.
389.77
-1.96%
IQV IQVIA Holdings Inc.
233.98
-2.85%
EXAS Exact Sciences Corporation
58.79
-7.04%
GH Guardant Health, Inc.
17.16
-5.19%